Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection
Marcus Altfeld(Leibniz Institute of Virology (LIV)), Bruce D. Walker(Howard Hughes Medical Institute), Todd M. Allen(Ragon Institute of MGH, MIT and Harvard), Jay A. Levy(Columbia University Irving Medical Center), Frederick Hecht(University of California, San Francisco), Rafick‐Pierre Sékaly(Emory University), Marylyn M. Addo(Universität Hamburg), Jürgen K. Rockstroh(University of Bonn), Margaret E. Feeney(University of California, San Francisco), Paul K. Lee(Massachusetts General Hospital), Xu G. Yu(Massachusetts General Hospital), Eric Rosenberg(Harvard University), James O. Kahn(San Francisco General Hospital), Daryld Strick(Massachusetts General Hospital), Martin Vogel(University of Bonn), Mary N. Johnston(Massachusetts General Hospital), Philip JR Goulder(Massachusetts General Hospital), Rika Draenert(Harvard University)
Cited by 355
Related Papers
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19
|Annals of Internal Medicine|2020|2.4k
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
|AIDS|2000|1k
CD8 <sup>+</sup> Lymphocytes Can Control HIV Infection in Vitro by Suppressing Virus Replication
|Science|1986|993
SARS-CoV-2 viral load is associated with increased disease severity and mortality
|Nature Communications|2020|978